IMV Overview
Latest debt-to-equity ratio for IMV: -4.38 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-4.38
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
IMV (IMV) currently reports a debt-to-equity ratio of -4.38. That is below the Healthcare sector average of 0.31. Use the charts on this page to explore IMV's debt-to-equity ratio history and peer comparisons.
IMV's debt-to-equity ratio of -4.38 is lower than the Healthcare sector average of 0.31. That is roughly 1519.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The debt-to-equity ratio is a valuation multiple that relates IMV's market price to a fundamental measure such as earnings, sales, or book value. At -4.38, IMV can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current debt-to-equity ratio of -4.38, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 0.31. From there, open related valuation or income-statement pages for IMV, and consider following IMV for alerts when major investors trade the stock.
IMV is classified in the Healthcare sector. On debt-to-equity ratio, it currently shows -4.38 versus a sector average near 0.31. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMV with unrelated industries.
